eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Alliance Pharmaceuticals
Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
Telephone: +44 (0)1249 466 966
Fax: +44 (0)1249 466 977
WWW: http://www.alliancepharma.co.uk
Medical Information e-mail: medinfo@alliancepharma.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 15/08/2011
SPC Anbesol Adult Strength Gel

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   29-Jul-2011
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Following an acquisition the Marketing Authorisation Holder is now Alliance

7          MARKETING AUTHORISATION HOLDER

 

Alliance Pharmaceuticals Limited

Avonbridge House

Bath Road

Chippenham

Wiltshire

SN15 2BB

UK

 

 

8          MARKETING AUTHORISATION NUMBER

 

PL 16853/0127
Updated on 27/09/2006 and displayed until 15/08/2011
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   03/2006
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 7 - change to marketing authorisation holder
Section 8 - change to PL number in line with above
Section 9 - new grant date in line with above
section 10 - revision of above text
Updated on 21/09/2005 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 03/07/2001 and displayed until 21/09/2005
Reasons for adding or updating:
  • No reasons supplied
Updated on 28/03/2001 and displayed until 03/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  lidocaine hydrochloride
  chlorocresol
  cetylpyridinium chloride